Literature DB >> 7685167

A nonimmunosuppressive triene-modified rapamycin analog is a potent inhibitor of peptidyl prolyl cis-trans isomerase.

T D Ocain1, D Longhi, R J Steffan, R G Caccese, S N Sehgal.   

Abstract

A triene-modified analog of the potent immunosuppressive agent rapamycin was found to be a potent inhibitor of the peptidyl prolyl cis-trans isomerase activity of human FKBP (Ki = 12.5 nM). This analog was not immunosuppressive in a thymocyte proliferation assay itself, but was able to antagonize the effect of rapamycin. This new analog should be useful as a mechanistic probe for macrocyclic immunosuppressants.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7685167     DOI: 10.1006/bbrc.1993.1563

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Detection of noncovalent FKBP-FK506 and FKBP-Rapamycin complexes by capillary electrophoresis-mass spectrometry and capillary electrophoresis-tandem mass spectrometry.

Authors:  Y L Hsieh; J Cai; Y T Li; J D Henion; B Ganem
Journal:  J Am Soc Mass Spectrom       Date:  1995-02       Impact factor: 3.109

2.  Hypersensitivity to rapamycin of BJAB B lymphoblastoid cells.

Authors:  J E Kay; M C Smith; V Frost; G Y Morgan
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

3.  Comparison of effects of sirolimus on cytokine dependent and cytokine independent proliferation.

Authors:  K L Molnar-Kimber; A Rhoad; L Warner; H Chen; S N Sehgal
Journal:  Inflamm Res       Date:  1995-08       Impact factor: 4.575

Review 4.  Nitroso Diels-Alder (NDA) reaction as an efficient tool for the functionalization of diene-containing natural products.

Authors:  Serena Carosso; Marvin J Miller
Journal:  Org Biomol Chem       Date:  2014-10-14       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.